Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / *W EXP 02/18/201
-
Total 13F shares
-
2,672,203
-
Share change
-
-14,983
-
Total reported value
-
$484,000
-
Price per share
-
$0.19
-
Number of holders
-
10
-
Value change
-
-$23,277
-
Number of buys
-
2
-
Number of sells
-
2
Institutional Holders of ONCOBIOLOGICS INC - *W EXP 02/18/201 (ONSIW) as of Q4 2016
As of 31 Dec 2016,
ONCOBIOLOGICS INC - *W EXP 02/18/201 (ONSIW) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,672,203 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, PERCEPTIVE ADVISORS LLC, Cormorant Asset Management, LLC, venBio Select Advisor LLC, MARSHALL WACE, LLP, PointState Capital LP, ACUTA CAPITAL PARTNERS, LLC, Jefferies Group LLC, Monashee Investment Management LLC, and MORGAN STANLEY.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.